创新对病人

We partner with patients, patient organizations, caregivers and clinicians to ensure that individual experiences, perspectives, needs and priorities are part of the clinical development process. For example, our approach to Patient-Centered Outcomes Research (PCOR) is grounded in collaborations with key stakeholders to understand patients' lived experiences, allowing us to develop strategies and solutions to help patients thrive.

\r\n"}}" id="text-a4cfd84d22" class="cmp-text">

我们与病人、病人组织护理人员和医生,以确保个人经验、观点,需求和重点是临床开发过程的一部分。狗万正网地址例如,我们的方法以病人为中心的研究结果(pc机)是建立在与关键利益相关者的合作了解病人的生活经验,让我们开发策略和解决方案帮助病人茁壮成长。

We believe clinical trials should reflect the populations we serve. Led by our dedicated Clinical Trial Diversity & Inclusion team, we work to design inclusive study protocols, enable under-represented populations to volunteer and continuously evaluate our clinical trial eligibility criteria against real-world datasets — so that all patients can have their voices heard. To learn more, read about our commitment to racial justice.

\r\n"}}" id="text-519a925238" class="cmp-text">

我们相信临床试验应该反映我们所服务的人群。由我们专门的临床试验多样性和包容的团队,我们致力于设计包容性研究协议,使弱势群体志愿者,不断评估我们的临床试验合格标准对真实数据集,这样所有的病人可以听到他们的声音。为了了解更多,了解我们对种族平等的承诺。

We work to better understand the experience of people living with a disease or condition, integrating their perspectives throughout our clinical development process to meet their specialized health needs. We develop robust patient journey maps to understand the transactional and emotional journey people experience from diagnosis through treatment and beyond.

\r\n"}}" id="text-cc895ad332" class="cmp-text">

我们工作为了更好地理解一种疾病或症状患者的经验,整合他们的观点在我们的临床开发过程来满足他们专门的卫生需求。狗万正网地址我们开发健壮的病人旅行地图了解事务和情感旅程人们从诊断到治疗经验。

From wearables to gaming platforms that measure disease symptoms and treatment outcomes, we're deploying digital health technology (DHT) tools that enable unprecedented data gathering and insights that inform our drug development process.
\r\n
\r\nFor diseases that are challenging to develop new therapies, our new tools help enable the development of objective and sensitive digital biomarkers — which aim to improve our ability to identify treatment responders faster and make clinical assessments more precise.
\r\n
\r\nWe also measure some outcomes in the real-world setting through connected sensor technology alongside COAs to provide a holistic understanding of patient experience. For example, we measure improvements in physical activity, sleep, and joint range of motion upon treatment in rheumatic conditions. In dermatological indications, images can be captured and assessed in real-time, enabling evidence-based treatment discussions based on disease activity.

\r\n"}}" id="text-6a427ae899" class="cmp-text">

从这套游戏平台,衡量疾病症状和治疗结果,我们部署数字医疗技术(DHT)工具,使前所未有的数据采集和见解,通知我们的药物开发过程。狗万正网地址

具有挑战性的疾病开发新疗法,我们的新工具帮助使的发展目标和敏感数字生物标志物——旨在提高我们的能力来确定治疗反应更快,使临床评估更精确。狗万正网地址

我们还测量一些成果在实际设置连接传感器技术与推广提供一个全面的了解病人的经验。例如,我们测量身体活动的改善,睡眠,和关节的活动范围在治疗风湿性疾病。在皮肤的迹象,实时图像可以捕获并评估,使循证治疗的讨论基于疾病活动。

RWE is clinical data derived from real patients during their real lives, which has the potential to provide a more comprehensive understanding of how a new therapeutic option will work by complementing the findings of traditional randomized clinical trials.
\r\n
\r\nRWE helps us understand disease burden, treatment patterns, patient behaviors and unmet needs, and treatment performance — particularly populations with disparities in care and outcomes — that cannot be studied through traditional clinical trials.

\r\n"}}" id="text-0ca8c0f093" class="cmp-text">

RWE临床数据来自真正的病人在现实生活中,也有可能提供一个更全面的了解一个新的治疗选择将如何工作的补充传统的随机临床试验的结果。

RWE帮助我们理解疾病负担、治疗模式,病人行为和未满足的需求,护理和治疗的性能,特别是人口差距和结果,无法通过传统的临床试验研究。